期刊
NATURE MEDICINE
卷 29, 期 7, 页码 1581-1582出版社
NATURE PORTFOLIO
DOI: 10.1038/d41591-023-00046-2
关键词
-
Nature Medicine reports on the latest translational and clinical research news, including FDA approval of Seres' orally administered pill SER-109 for the treatment of recurrent Clostridioides difficile infection.
Nature Medicine explores the latest translational and clinical research news, with FDA approval of Seres' orally administered pill SER-109 for the treatment of recurrent Clostridioides difficile infection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
